MUIR GLENN P

Director Muir Glenn P bought 25,000 shares of STIM at $0.80 on 2024-09-05; stock now $0.78, -83.8% from 52-week high of $4.81.

Director Muir Glenn P purchased 25,000 shares at $0.80 on 2024-09-05, expanding his holdings by 9.4% from 264,818 to 289,818 shares. This follows three prior open-market purchases at STIM within the preceding two weeks (2024-08-14, 2024-08-20, 2024-08-28, 2024-08-29), indicating a sustained accumulation pattern during a period of acute price pressure. The stock is now trading at $0.78, down 83.8% from its 52-week high of $4.81 and down 58.3% over the prior 30 days. The company is unprofitable, reporting net income of -$9,832,000.00 on quarterly revenue of $16,450,000.00. While the director's track record shows 4 prior open-market buys across all tickers, the measurable outcomes on those earlier STIM purchases remain unclear. Investors should monitor whether this repeated accumulation at depressed levels reflects conviction in a turnaround or simply persistence amid deteriorating fundamentals.

Director Muir Glenn P purchased 25,000 shares at $0.85 over 2 days; stock down 81.7% from 52-week high to $0.88.

Director Muir Glenn P made 2 separate purchases totaling 25,000 shares for $21,250.00 at $0.85 on August 28–29, 2024, increasing his holdings by 10.4% to 264,818 shares. This is his third consecutive buy at Neuronetics within a 14-day window (prior buys on 2024-08-14 and 2024-08-20), yet the stock has declined 52.9% over the past 30 days and trades 81.7% below its 52-week high of $4.81. The company reported $16.4M quarterly revenue with a net loss of $9.8M and remains unprofitable. The repeated purchases at steeply discounted prices coincide with severe stock deterioration, but the timing of these earlier buys cannot yet be measured (90-day outcomes are not yet determinable). Without FLAGS indicating a structured trading plan, the rapid consecutive accumulation at deeply depressed valuations on declining volume warrants observation of whether this pattern continues or reverses.

Director Glenn P Muir buys 25,000 STIM shares at $1.00 on 2024-08-20; stock trading -79.4% from 52-week high, company unprofitable.

Director Glenn P Muir purchased 25,000 shares at $1.00 on 2024-08-20, increasing his holdings to 239,818 shares, an 11.6% addition to his pre-transaction position. The purchase occurred as Neuronetics trades at $0.99 current price, representing -79.4% from its 52-week high of $4.81, with the stock down -48.2% over the trailing 30 days and -57.0% over 90 days. Fundamental performance remains challenging: the company reported net income of $-9,832,000.00 on quarterly revenue of $16,450,000.00 and remains unprofitable on a full-year basis, though annual revenue growth stands at 9.4%. This purchase was preceded by Muir's prior buy on 2024-08-14, indicating back-to-back acquisitions during a pronounced market decline, though measurable outcomes from that prior trade are not yet available.

Director MUIR GLENN P bought 25,171 shares of STIM at $0.75 on 2024-08-14; stock now -44.0% over 30 days, -76.7% from 52-week high.

Director Muir Glenn P purchased 25,171 shares at $0.75, increasing holdings by 13.3% to 214,818 shares. The purchase occurred in a context of severe price deterioration: the stock has declined -44.0% over the past 30 days and trades at $1.12, which is -76.7% below its 52-week high of $4.81. Neuronetics is currently unprofitable with net income of $-9,832,000.00 against quarterly revenue of $16,450,000.00, though the company posted annual revenue growth of 9.4%. This director-level accumulation at a 52-week low amid sharp recent losses and persistent unprofitability represents a meaningful commitment of capital and warrant investor scrutiny into the rationale and forward-looking assumptions behind the transaction.